Information Provided By:
Fly News Breaks for January 6, 2017
HWAY
Jan 6, 2017 | 06:02 EDT
Jefferies analyst David Styblo upgraded Healthways to Buy saying the standalone business value is underappreciated following divestitures of underperforming assets. The analyst also believes the company's 2017 guidance could bring upside to expectations. He upped his price target for the shares to $29 from $26.
News For HWAY From the Last 2 Days
There are no results for your query HWAY